ghk-cu administration subcutaneous or topical - Peptide for Collagen, Healing & Anti-Aging ghk-cu peptide subcutaneous dosing protocol
Description
J Intensive Care Med 2005;20:6375
Studies have shown that a number of very different neuropsychiatric diseases and symptoms can be completely treated with B12 (1-5)
1) based on the available chemical data from ChemSpider 27
Because the vial is co-formulated 1:1, every dose drawn delivers an equal split of BPC-157 and TB-500
Step 4: Follow-up and adjustment Most protocols include scheduled follow-ups at 4 and 8 weeks
Step three would still require years of clinical trials none of these compounds have undergone
